Long-Term Follow-Up of Subjects Treated With NTLA-2001
Status: Enrolling_by_invitation
Location: See all (4) locations...
Study Type: Observational
SUMMARY
This is a follow-up study of subjects who received NTLA-2001 in a previous clinical trial as an observational evaluation of the long-term effects of the investigational therapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• A subject has completed or discontinued from an Intellia-sponsored clinical study in which a complete or partial dose of NTLA-2001 was received.
• A subject has provided informed consent for the LTFU study.
Locations
Other Locations
France
Clinical Trial Site
Paris
New Zealand
Clinical Trial Site
Auckland
Sweden
Clinical Trial Site
Umeå
United Kingdom
Clinical Trial Site
London
Time Frame
Start Date: 2023-07-10
Completion Date: 2038-03
Participants
Target number of participants: 72
Related Therapeutic Areas
Sponsors
Leads: Intellia Therapeutics